ClinicalTrials.govpublic full text
Safety, Tolerability, Pharmacokinetics and Efficacy of LMB763 in Patients With NASH
non-alcoholic steatohepatitis nash, non-alcoholic steatohepatitis, nash, fatty liver disease, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1032275
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.